 WALTHAM, Mass., Jan. 07, 2021 GLOBE NEWSWIRE -- Entasis Therapeutics Holdings Inc. NASDAQ: ETTX, a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced that Dr. Manos Perros, President and Chief Executive Officer of the Company, will present at the virtual H.C. Wainwright BioConnect 2021 Conference being held January 11-14, 2021. 